These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3872866)

  • 21. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells.
    Navarrete C; Fernandez N; Alonso MC; Festenstein H
    Hum Immunol; 1986 May; 16(1):52-68. PubMed ID: 3519548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for the expression of three different BoLA-class II molecules on the bovine BL-3 cell line: determination of a non-DR non-DQ gene product.
    Ababou A; Goyeneche J; Davis WC; Lévy D
    J Leukoc Biol; 1994 Aug; 56(2):182-6. PubMed ID: 7520928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of an HLA-DRw52-associated determinant on DR beta 1 molecules.
    Ballas M; Eiermann TH; Wölpl A; Goldmann SF
    Tissue Antigens; 1990 Nov; 36(5):187-93. PubMed ID: 1710076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse monoclonal anti-Ia antibodies recognize cross-reacting determinants expressed on distinct subsets of human Ia-like cell-surface molecules.
    Birnbaum D; Rohner C; Dubreuil P; Bourgue F; Pierres M; Goridis C
    Mol Immunol; 1983 May; 20(5):511-20. PubMed ID: 6192324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody to a supertypic determinant associated with HLA-DRw52.
    Eiermann TH; Krause S; Wölpl A; Ballas M; Goldmann SF
    Hybridoma; 1989 Aug; 8(4):467-74. PubMed ID: 2476377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.
    Shackelford DA; Mann DL; van Rood JJ; Ferrara GB; Strominger JL
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4566-70. PubMed ID: 6974868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new allodeterminant on HLA-DQ molecules carrying the DQw3 specificity.
    Tanigaki N; Tosi R; Katagiri M; Ferrara GB
    Hum Immunol; 1985 Dec; 14(4):379-90. PubMed ID: 2416721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal mouse anti-I-Ak and anti-I-Ek antibodies cross-reacting with HLA-DR supertypic and subtypic determinants rather than classical DR allelic specificities.
    Pierres M; Mercier P; Madsen M; Mawas C; Kristensen T
    Tissue Antigens; 1982 Apr; 19(4):289-300. PubMed ID: 6179258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules.
    Crepaldi T; Richiardi P; Malavasi F; Carbonara AO; Igarashi M; Ferrone S
    Tissue Antigens; 1985 Jul; 26(1):25-34. PubMed ID: 2412306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunochemical analysis of the Ia polymorphisms among the family of DR7-associated HLA-D specificities.
    Karr RW
    J Immunol; 1986 Feb; 136(3):999-1006. PubMed ID: 3510255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-dimensional gel electrophoretic analysis of the MT3 and DR4 molecules from the different D-typed cells.
    Suzuki M; Yabe T; Satake M; Juji T; Hamaguchi H
    J Exp Med; 1984 Sep; 160(3):751-8. PubMed ID: 6206187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
    Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
    Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cross-reactive mouse anti-I-Ek monoclonal antibody detects an HLA-DR polymorphism linked to HLA-DR1.
    Birnbaum D; Dosseto M; Bourgue F; Pierres M; Kourilsky FM
    Mol Immunol; 1982 Jun; 19(6):755-64. PubMed ID: 6981060
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of three class II antigens, DR7, MB2, and MT3, from a homozygous human cell line.
    Shackelford DA; Strominger JL
    Hum Immunol; 1984 Mar; 9(3):159-74. PubMed ID: 6199337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA class II restriction repertoire of antigen-specific T cells. II. Evidence for a new restriction determinant associated with DRw52 and LB-Q1.
    Ottenhoff TH; Elferink DG; Termijtelen A; Koning F; de Vries RR
    Hum Immunol; 1985 Jun; 13(2):117-23. PubMed ID: 2409061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mouse monoclonal antibody detecting a DR-related MT2-like specificity: serology and biochemistry.
    Koning F; Schreuder I; Giphart M; Bruning H
    Hum Immunol; 1984 Apr; 9(4):221-30. PubMed ID: 6232245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.